Ocata Therapeutics, Inc. , a clinical stage biotechnology company developing regenerative ophthalmology therapeutics, announced today that it will host a conference call on Thursday, March 12, 2015 at 4:30 p.m. EDT, during which it will provide a corporate update for the fourth quarter and full year of 2014. Interested parties may access the call live by dialing 471-3843 or 457-2664 and using conference ID 7292518.
http://ift.tt/18bPgXm
http://ift.tt/18bPgXm
No comments:
Post a Comment